Devin W. Steenkamp, MBChB
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Endocrinology, Diabetes, Nutrition & Weight Management

MBChB, University of Pretoria



Devin Steenkamp is an endocrinologist with a particular interest in type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine and his clinical practice and research interests are focused on the application of diabetes technologies in care

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research





Continuous glucose monitoring in a community study: determinants and prediction of diabetes mellitus development in the Framinghm Heart Study.
04/01/2022 - 03/31/2027 (PI)
Trustees of Boston University, BUMC National Institute o
1R01DK129305-01

INHALE-3 A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Afrezza Combined with Degludec (Tresiba) Versus Usual Care in Adults with Type 1 Diabetes
06/21/2023 - 06/20/2026 (PI)
JAEB Center For Health Research, Inc.

TP-0013437 A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)
06/01/2023 - 05/31/2026 (PI)
JAEB Center For Health Research, Inc.

Quality Improvement (Q1) Program
04/28/2021 - 06/30/2025 (PI)
T1D Exchange, Inc.

ADC-US-RES-19185: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People with T2 Diabetes
05/11/2022 - 05/10/2025 (PI)
Abbott Laboratories

FOCUS - Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes
07/01/2019 - 07/31/2024 (PI)
Novo Nordisk

REDUCING INEQUITIES IN DIABETES TECHNOLOGY
02/01/2023 - 03/31/2024 (PI)
T1D Exchange, Inc.

F3Z-MC-IORN Meal-centric Insulin Dosing for Optimized Post-Prandial Glucose Control in People Using Multiple Daily Injections
06/04/2021 - 05/01/2023 (PI)
Lilly USA, LLC

Glycemla Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
08/01/2014 - 01/28/2023 (PI)
Mass General Hosp NIH-NIDDK

SWITCH Pro: A randomised, cross-over, open-label, multi-centre trial comparing the effect of…
09/23/2018 - 08/25/2021 (PI)
Novo Nordisk

Showing 10 of 15 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Steenkamp D, Brouillard E, Aia C, Fantasia K, Sullivan C, Atakov-Castillo A, Wolpert H. Reducing Inequity in the Use of Automated Insulin Delivery Systems by Adults with Type 1 Diabetes: Key Learnings from a Safety Net Diabetes Clinic Program. Endocr Pract. 2024 Apr 05. PMID: 38583773; DOI: 10.1016/j.eprac.2024.04.001;
     
  2. Steenkamp DW, Fantasia KL, Wolpert HA. Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes. Endocrinol Metab Clin North Am. 2024 Mar; 53(1):67-80.View Related Profiles. PMID: 38272599; DOI: 10.1016/j.ecl.2023.07.001;
     
  3. Ferkowicz MJ, Verma A, Barwinska D, Ferreira RM, Henderson JM, Kirkpatrick M, Silva PS, Steenkamp DW, Phillips CL, Waikar SS, Sutton TA. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2023 Aug 03; 19(2):266-75.View Related Profiles. PMID: 37533147; PMCID: PMC10861111; DOI: 10.2215/CJN.0000000000000276;
     
  4. Steenkamp DW, Cheney MC, Ju Z, Rodbard D, Wolpert HA. Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes. J Endocr Soc. 2023 Mar 06; 7(5):bvad038.View Related Profiles. PMID: 37035501; PMCID: PMC10074392; DOI: 10.1210/jendso/bvad038;
     
  5. Williams ME, Steenkamp D, Wolpert H. Making sense of glucose sensors in end-stage kidney disease: A review. Front Clin Diabetes Healthc. 2022; 3:1025328.View Related Profiles. PMID: 36992784; PMCID: PMC10012164; DOI: 10.3389/fcdhc.2022.1025328;
     
  6. Steenkamp DW, Piarulli A, Middelbeek RJW, Wolpert HA. Severe hypoglycaemia while using a hybrid closed-loop insulin pump system: A reminder of the continued importance of patient education for pre-emptive hypoglycaemia mitigation. Diabet Med. 2023 Mar; 40(3):e14975.View Related Profiles. PMID: 36251520; DOI: 10.1111/dme.14975;
     
  7. Marks BE, Mungmode A, Neyman A, Levin L, Rioles N, Eng D, Lee JM, Basina M, Hawah-Jones N, Mann E, O'Malley G, Wilkes M, Steenkamp D, Aleppo G, Accacha S, Ebekozien O. Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2022; 41(1):35-44. PMID: 36714248; PMCID: PMC9845085; DOI: 10.2337/cd22-0071;
     
  8. Ebekozien O, Mungmode A, Buckingham D, Greenfield M, Talib R, Steenkamp D, Haw JS, Odugbesan O, Harris M, Mathias P, Dickinson JK, Agarwal S. Achieving Equity in Diabetes Research: Borrowing From the Field of Quality Improvement Using a Practical Framework and Improvement Tools. Diabetes Spectr. 2022; 35(3):304-312. PMID: 36072814; PMCID: PMC9396719; DOI: 10.2337/dsi22-0002;
     
  9. Modzelewski KL, Murati J, Charoenngam N, Rehm C, Steenkamp DW. Delays in Continuous Glucose Monitoring Device Initiation: A Single Center Experience and a Call to Change. Diabetes Technol Ther. 2022 Jun; 24(6):390-395.View Related Profiles. PMID: 35099277
     
  10. Fantasia KL, Demers LB, Steenkamp DW, Modzelewski KL. An Opportunity for Improvement: Evaluation of Diabetes Technology Education Among Adult Endocrinology Training Programs. J Diabetes Sci Technol. 2023 Sep; 17(5):1274-1283.View Related Profiles. PMID: 35135342; PMCID: PMC10563541; DOI: 10.1177/19322968221077132;
     
Showing 10 of 50 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 50 publications over 13 distinct years, with a maximum of 9 publications in 2017

YearPublications
20111
20134
20145
20152
20164
20179
20182
20196
20202
20215
20226
20233
20241

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Type 1 Diabetes Mellitus
Proinsulin C Peptide
MODY

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
Contact for Mentoring:

75 E. Newton St
Boston MA 02118
Google Map


Steenkamp's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department